F-Prime Capital releases the 2024 State of Robotics report Read more

Engrail closes $157M series B, fueled by investors' renewed interest in neuropsychiatry Read more

FDA greenlights Orchard's gene therapy Lenmeldy for rare and fatal disease Read more

We create and invest in healthcare and technology companies that impact lives all over the world.


Our global portfolio is always growing

We have nearly 300 companies in our portfolio including over 30 that we started from scratch. Our global portfolio is spread across the Americas, Europe, and Asia.


Over four and a half billion dollars under management

Big ideas need big investments. We have the heft and history to make a significant impact in the world.


We create and invest in leading companies in therapeutics, medtech, and health IT & services.

View Healthcare


We've been partnering with fearless founders for over 50 years.

View Technology

Big global funds, small local teams

  • Cambridge
    1 Main St.
    13th Floor
    Cambridge, MA 02142
  • London
    33 Foley Street
    London, W1W 7TL
  • San Francisco
    140 New Montgomery Street
    2nd Floor, Suite A
    San Francisco, CA 94105
abstract image of globe